Shared publicly  - 
 
FDA Staff Has Cautious Praise for New ICD
WASHINGTON -- A novel subcutaneous implantable cardioverter-defibrillator has met its primary safety and effectiveness endpoints, but questions remain regarding the totality of safety and efficacy, according to FDA staff reviewers.

http://www.medpagetoday.com/PublicHealthPolicy/FDAGeneral/32317
1
Add a comment...